Why Walgreens, CVS retail pharmacies are struggling

admin
By admin
19 Min Read

The abundance of Walgreens and CVS Well being shops makes them handy for every time Shriya Raghavan, a analysis affiliate based mostly in Philadelphia, wants to choose up requirements like gum, deodorant and cleaning soap. 

However she stated she typically has to attend for workers to unlock cupboards or stand in prolonged strains to choose up prescriptions as pharmacists juggle duties.

These are simply a number of the methods Walgreens and CVS are falling out of favor with shoppers, in a development that has hit their earnings and inventory costs and compelled them to rethink their methods. They’re signs of deeper points plaguing retail pharmacy chains, which pivoted from years of retailer expansions to shuttering tons of of areas throughout the U.S. to shore up earnings. 

Inventory Chart IconInventory chart icon
hide content

Shares of each CVS and Walgreens have tumbled within the final 10 years, however CVS has fared higher among the many two.

Among the many largest issues for the chains, reimbursement charges for prescribed drugs have fallen. Inflation, softer client spending, theft, and competitors from Amazon and grocery shops are additionally making it tough for drugstores to show a revenue on the entrance of the shop, the place they promote all the things from pantry staples to make-up and cleansing provides.

There’s additionally widespread burnout amongst pharmacy workers, a lot of whom complain about understaffing and growing workloads.

A lot of these points aren’t new. Whereas CVS and Walgreens bought a brief enhance from Covid vaccinations and check gross sales through the peak of the pandemic, they now face a harsh actuality: the retail pharmacy mannequin could also be damaged. 

“As things have started to normalize, we’re reverting back to the challenges that the retail pharmacy industry had faced even before Covid,” Jefferies analyst Brian Tanquilut instructed CNBC. “I think most of these pharmacies are realizing that fundamentally, their businesses have not really changed.” 

The outside of a CVS pharmacy retailer is seen on August 07, 2024 in Austin, Texas. 

Brandon Bell | Getty Photos

Falling retail pharmacy revenue margins solely add to the woes at each Walgreens and CVS. 

Whereas Walgreens struggles with its push into main care, CVS’ backside line is getting battered by greater medical prices in its insurance coverage enterprise. CVS earlier this month slashed its full-year revenue outlook for the third consecutive quarter and introduced $2 billion in new price cuts over a number of years as these greater medical prices squeeze the insurance coverage business. 

It isn’t simply these two chains: Ceremony Help, as soon as a viable competitor, declared chapter final yr and is closing tons of of retailer areas because it restructures.

Wall Road hasn’t been completely happy. Shares of Walgreens are down practically 60% this yr and 80% over the past decade. CVS’ inventory is down nearly 30% each for this yr and the final 10 years. In the meantime, Ceremony Help’s frequent inventory was delisted from the New York Inventory Alternate in October. 

Nonetheless, retail pharmacy chains stay an necessary fixture of the U.S. health-care system that tens of tens of millions of Individuals depend on. They might simply must reinvent themselves. 

“The retail pharmacy industry is going through a period of soul-searching, trying to understand the best model to reach the consumer,” stated GlobalData retail managing director Neil Saunders. “Consumer habits have changed, some of the economics of running drugstores and pharmacies have changed and the retailers in the sector are really having to reappraise how they do business to maintain profitability and maintain a viable business model.”

Listed below are the primary components difficult the pharmacy enterprise, and what CVS and Walgreens are doing to adapt.

Falling pharmacy reimbursement charges

A lot of the ache for retail pharmacies comes from decrease prescription drug reimbursement charges. 

Pharmacies sometimes purchase their medicines from a distributor after which get reimbursed by pharmacy profit managers, or PBMs. The highly effective drug provide middlemen additionally negotiate reductions with producers on behalf of insurers and create lists of medicines lined by well being plans.

The three largest PBMs – CVS Well being’s Caremark, UnitedHealth Group‘s Optum Rx and Cigna‘s Specific Scripts – deal with nearly 80% of all prescriptions within the U.S.

Pharmacies have accused PBMs of setting decrease reimbursement charges, which, in some circumstances, can imply pharmacies receives a commission lower than the price of shopping for and shelling out a prescription. These middlemen are additionally accused of providing “take it or leave it” contracts when negotiating reimbursements with pharmacies, successfully forcing them to simply accept decrease charges to allow them to keep entry to sufferers lined by PBMs. 

“There’s no leverage. There’s no negotiating power on the side of the retail pharmacies,” Tanquilut instructed CNBC. “So we’ve seen a consistent pressure on margins on the pharmacy side over the last several years to the point where that’s a huge challenge.” 

The working margin for Walgreens’ U.S. retail pharmacy unit was -5% final yr, down from 3.9% in 2019 and 4.4% in 2015. In the meantime, CVS’ working margin for its pharmacy and client wellness enterprise was 4.6% final yr, up from 3.3% in 2022 however down from 8.5% in 2019 and 9.9% in 2015.

CVS has a slight aggressive benefit over Walgreens because it has its personal PBM, and the margin strain from Caremark is probably going “not as severe” as it’s for different PBMs, Tanquilut stated.

CVS in December additionally launched a brand new pharmacy reimbursement mannequin known as CostVantage, which is able to launch firstly of subsequent yr and use what the corporate calls a “transparent” method to find out a medicine’s worth. A CVS spokesperson stated it can present extra readability and predictability for shoppers.

However some analysts instructed CNBC that it is nonetheless unclear how efficient that new mannequin shall be.

In the meantime, Saunders stated extra shoppers are utilizing on-line pharmacy providers comparable to PillPack, a subsidiary of Amazon Pharmacy, to get their prescription medicines. He famous that on-line pharmacy achievement stays “fairly small in the scheme of things,” however stated it’s “definitely growing and putting a little bit of pressure on some of the traditional pharmacy chains.”  

Entrance-of-store woes 

A Walgreens truck parks close to a CVS Pharmacy on March 10, 2023 in New York Metropolis.

Leonardo Munoz | Corbis Information | Getty Photos

E-commerce rivals, discounters and big-box retailers are an excellent larger menace to the retail aspect of Walgreens’ and CVS’ pharmacy companies. 

As competitors mounts, the chains’ on-line retail presence has additionally lagged behind these of Amazon and different retailers like Walmart and Goal, in line with Leerink Companions analyst Michael Cherny. 

“It wasn’t as likely that an individual pre-Covid, or even the early days of Covid, would think first and foremost of going to CVS.com or Walgreens.com for shopping,” Cherny stated. “[CVS and Walgreens] were behind on e-commerce.” 

Inflation can also be squeezing shoppers, who’ve develop into extra prudent with their purchases. A budget-conscious shopper is extra prone to store at retailers together with Walmart, a greenback retailer or Costco, regardless of the comfort the retail pharmacies provide, Cherny famous.

Brittainy Lynn, a 38-year-old freelancer based mostly in Austin, Texas, stated it “seems like prices are really high” at Walgreens and CVS in contrast with different shops. 

“It is not my first choice,” Lynn instructed CNBC. “Walmart or Goal is generally where I find things I need for the cheapest price. I do frequent Greenback Tree as well, but not really for essentials.” 

Walgreens and CVS have blamed weaker retail gross sales partially on shoppers watching their spending.

Earlier this month, CVS stated same-store gross sales on the entrance of the shop have been down roughly 4% through the second quarter from the identical interval a yr in the past, which displays a “general softening of consumer demand.” 

Walgreens in June stated same-store retail gross sales decreased 2.3% through the fiscal third quarter in contrast with the year-earlier interval. The corporate stated its U.S. retail pharmacy enterprise confronted “significant challenges” in a “worse-than-expected consumer environment.” 

Walgreens and CVS have each elevated their deal with their private-label merchandise to lure in customers who’ve traded down from nationwide manufacturers to beat inflation. 

In a press release, a Walgreens spokesperson stated the corporate is seeing “strong success among our own brand products,” with model penetration “growing quite nicely.” They added that the corporate is increasing its number of merchandise, including 37 new objects alone within the second quarter. That “perfectly complements consumer focus on value,” the spokesperson stated.

Walgreens extra uncovered to retail pharmacy strain

Whereas the foremost chains face lots of the similar hurdles, Walgreens is probably going extra uncovered to the pressures on its retail pharmacy enterprise than CVS is, Evercore ISI analyst Elizabeth Anderson instructed CNBC. 

CVS operates a PBM and the nation’s third-largest well being insurer, Aetna, which might assist offset points on the retail pharmacy aspect. 

Walgreens and VillageMD

Supply: Walgreens

CVS’ retail pharmacy unit was the second-biggest contributor to gross sales final yr, raking in $116.76 billion. The corporate’s well being providers section, which operates Caremark and primary-care supplier Oak Road Well being, booked practically $187 billion in gross sales. 

In the meantime, Walgreens will get the overwhelming majority of its income from its U.S. retail pharmacies. That enterprise unit took in greater than $109 billion final yr, dwarfing the $21.83 billion from its worldwide section and practically $1.8 billion from its health-care unit. 

Walgreens’ worldwide section operates greater than 3,000 retail shops overseas, together with areas of U.Ok.-based well being and wonder retailer Boots. The corporate’s health-care unit provides main care, pressing care and post-acute care providers, in addition to a specialty pharmacy, amongst different providers. 

Whilst Walgreens tries to diversify its enterprise, the corporate has been “playing catch-up” with CVS within the health-care house, in line with Jeffries’ Tanquilut. 

Retail giants and pharmacies have been pushing to ship medical care on to sufferers, which might assist them seize a bigger slice of the greater than $4 trillion U.S. health-care business. 

However a number of firms, together with Amazon, Walmart, CVS and Walgreens, are feeling the ache from bets on main care. That is as a result of constructing clinics requires loads of capital, and the areas sometimes lose cash for a number of years earlier than turning into worthwhile, in line with Tanquilut. 

In contrast to CVS, Walgreens might doubtlessly exit that market altogether. The corporate stated in a securities submitting final week it’s contemplating a sale of its primary-care supplier VillageMD.

Walgreens invested $1 billion in VillageMD in 2020, then one other $5.2 billion a yr later to develop into its majority proprietor. However Walgreens began closing clinic areas final yr. In March, the corporate recorded a hefty practically $6 billion cost associated to the decline in worth of its funding in VillageMD. 

What’s the way forward for the retail pharmacy? 

Retail pharmacies possible will not disappear quickly, particularly because the American inhabitants ages and extra individuals want to choose up prescriptions, Evercore’s Anderson stated. 

However she stated they might not must “exist in their current form.” That would doubtlessly imply growing their on-line presence, now not promoting sure merchandise like greeting playing cards and shrinking retailer footprints.

“I think there’ll be some experimentation with models there. It’s more of a question of what the new retail pharmacy model will look like,” Anderson instructed CNBC. 

Walgreens has opened roughly 100 smaller-format shops, which have fewer front-of-store objects and over-the-counter medicines and have the corporate’s branded merchandise, a spokesperson stated in a press release. Walgreens plans so as to add extra “mini drugstores” this yr.

Walgreens “mini-drugstores” being examined throughout the U.S. 

Courtesy: Walgreens

The corporate can also be piloting a Chicago retailer location that focuses on “convenience and speed through digital pickup, pharmacy and grab-and-go solutions,” Walgreens stated on its web site. Most prescription or retail orders will be positioned and crammed at a counter, which might deter theft. 

One other location in Aubrey, Texas, strikes the pharmacy to the entrance of the shop in a departure from the standard mannequin.

The corporate’s web site stated it doesn’t plan to roll out extra pilot shops till “learnings about what works and what doesn’t are better understood.” 

Extra CNBC well being protection

In the meantime, a CVS spokesperson stated the corporate is “innovating to meet our customers’ and patients’ varying needs.” The spokesperson pointed to the corporate’s private-label manufacturers, assortment of nationwide manufacturers, and loyalty program that provides reductions and advantages for sufferers. 

The corporate has additionally opened Oak Road Well being primary-care facilities aspect by aspect with CVS pharmacies in Texas and Illinois, with plans to introduce round two dozen extra by the top of the yr. 

Shuttering shops to shore up earnings

Within the meantime, CVS and Walgreens are slicing prices. 

Walgreens in June introduced plans to shutter a “significant” variety of its 8,600 U.S. shops. The corporate’s CEO, Tim Wentworth, stated solely 75% of the chain’s areas have been worthwhile, and that a good portion of the opposite quarter might shutter by 2027.

In a press release, a Walgreens spokesperson stated, “We have recently exhibited the ability to, and will continue to make difficult decisions that benefit our business, as we identify opportunities that unlock value, validate existing pathways and lead [Walgreens] into a successful future.”

In 2021, CVS introduced it was shuttering 900 shops, or practically 10% of its U.S. retail areas, over a three-year interval. CVS executives earlier this month stated the corporate is on observe to fulfill that aim by the top of the yr, with 851 shops closed so far. 

In a press release, a CVS spokesperson stated the shop closure selections are based mostly on inhabitants shifts, client spending patterns and a given group’s retailer density, amongst different components. Even after the closures, 85% of individuals within the U.S. will nonetheless dwell inside 10 miles of a CVS pharmacy, the spokesperson famous.

Amar Singh, senior director at retail consulting firm Kantar Group, stated shuttering underperforming areas might assist Walgreens and CVS right-size their enterprise and determine “the right equation” for his or her shops that may win again customers and shore up earnings. 

However retailer closures might make it more durable for a lot of Individuals to get prescriptions, as pharmacy deserts develop into extra frequent in underserved communities throughout the U.S. 

In addition they could do little to repair a number of the deeper points plaguing retail pharmacies, in line with Saunders. For instance, he stated addressing declining pharmacy reimbursement charges could require laws and lobbying, and “getting that done is almost possible.” 

“In some ways, closing stores is a reaction to the problem. It’s not the solution to the problem,” Saunders stated. “But longer term, if other things don’t change, they’ll probably find themselves in the same position in 10 years time where they have to close more stores.” 

Share This Article